Overview

A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease

Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of a carboxymethylcellulose based eye drop formulation compared with carboxymethylcellulose based preservative-free lubricant eye drops (OPTIVE™) in subjects with dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Lubricant Eye Drops
Ophthalmic Solutions
Tetrahydrozoline